Related Items

Bye Bye, Biotech

Pharmaceutical maker QLT established a special committee to evaluate all available strategic alternatives, including a possible sale


By KEN MacFADYEN

January 2008

Pharmaceutical maker QLT established a special committee to evaluate all available strategic alternatives, including a possible sale.

The full article is available to Mergers Unleashed subscribers only

Are you an existing M&A Magazine subscriber and/or ACG member?

 Yes     No

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.